AzTrials
AzTrials

Gross Motor Development DelayNCT06139549

The Effects of Playful Pathways

An observational study of Gross Motor Development Delay, run by Arkansas Colleges of Health Education at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate infants ages 0-6 months of age before and after an 8 week developmental and educational "caregiver and baby" interactive program as well as 3 month following the conclusion of the program. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Gross Motor Development Delay
What is being tested?
Gross motor development group session
How many people
10 participants
Where
1 siteUnited States
Study dates
20 Sep 2023to 20 Feb 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Infants ages 0-6 months Caregivers age 18 and older

Who may be able to join

  • 1. All babies typically developing or any diagnosis ages 0 - 6 months
  • At least 18 years of age
  • Able to communicate in and read English
  • Parent/caregiver of baby ages 0 - 6 months who is participating in the program
  • Ability to provide transportation to/from research site(s)

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

LaVona Traywick, PHD contact

4794016023

lavona.traywick@achehealth.edu

Allison N Young, DPT contact

4794143238

allison.young@achehealth.edu

United States1 site, 1 recruiting
  • Arkansas Colleges of Health Education

    Fort Smith, Arkansas, 72916

    Allison N Young, DPT, 479-401-6029, allison.young@achehealth.edu

    Recruiting

Other trials in United States

About this study

Official title: The Effects of Playful Pathways, a Play-Based Developmentally Focused Group Program, and How it Affects Caregivers' Health Literacy and Self-Efficacy and Influences Outcomes for Infants

The purpose of this study is to evaluate infants ages 0-6 months of age before and after an 8 week developmental and educational "caregiver and baby" interactive program as well as 3 month following the conclusion of the program. The researchers aim to screen and identify developmental delays and the effects of the 8 week program on gross motor development as well as explore parent perceptions of the program.

The aim of this study is to assess the physical, social, and emotional outcomes of an interactive group program for infants 0-6 months and their families/caregiver.

Being tested
Gross motor development group session
Keywords
INFANT, GROSS MOTOR DEVELOPMENT, GROUP SESSION

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gross motor development group sessionOther

    Group session for gross motor development

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. DAYC-2

    measure of gross motor development

    Measured: 9/20/23 - 2/20/24

  2. PHLAT-8

    measure of health literacy

    Measured: 9/20/23 - 2/20/24

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Nov 2023
  2. Study start20 Sep 2023
  3. Primary completion8 Nov 2023 (estimated)
  4. Study completion20 Feb 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06139549
Sponsor's protocol ID
ACHEFALL2023PP
Status last verified
Nov 2023
First submitted
17 Sep 2023
Last updated
18 Nov 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Alkhazrajy, L. A., & Aldeen, E. R. S. (2017). Assessment of mothers knowledge regarding the developmental milestone among children under two years in Iraq. American Journal of Applied Sciences, 14(9), 869-877.

  • Aoyama T, Hikihara Y, Watanabe M, Wakabayashi H, Hanawa S, Omi N, Takimoto H, Tanaka S. Association Between Age of Achieving Gross Motor Development Milestones During Infancy and Body Fat Percentage at 6 to 7 Years of Age. Matern Child Health J. 2022 Feb;26(2):415-423. doi: 10.1007/s10995-021-03238-9. Epub 2021 Oct 16.

    PubMed 34655425

Questions about this trial

What is this clinical trial studying?

An observational study of Gross Motor Development Delay, run by Arkansas Colleges of Health Education at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact LaVona Traywick, PHD (4794016023, lavona.traywick@achehealth.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

DAYC-2 (time frame: 9/20/23 - 2/20/24). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06139549, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in